Back to ASND
STATE STREET CORP ASND Position History
Ascendis Pharma A/S • Healthcare
Quarters held
22
Latest value
$137.1M
Q2 2026
Peak value
$137.1M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $12.3M |
| Q4 2023 | $3.9M |
| Q1 2024 | $14.4M |
| Q1 2024 | $5.2M |
| Q2 2024 | $12.7M |
| Q2 2024 | $4.8M |
| Q3 2024 | $14.8M |
| Q3 2024 | $10.7M |
| Q4 2024 | $15.1M |
| Q4 2024 | $9.9M |
| Q1 2025 | $14.2M |
| Q1 2025 | $10.4M |
| Q2 2025 | $13.5M |
| Q2 2025 | $10M |
| Q3 2025 | $16.7M |
| Q3 2025 | $12.2M |
| Q4 2025 | $17.7M |
| Q4 2025 | $14.5M |
| Q1 2026 | $18.4M |
| Q1 2026 | $20M |
| Q2 2026 | $137.1M |
| Q2 2026 | $137.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $137.1M | 514.0K | — | — |
| Q2 2026 | $137.1M | 514.0K | — | — |
| Q1 2026 | $20M | 87.3K | — | — |
| Q1 2026 | $18.4M | 12.45M | — | — |
| Q4 2025 | $14.5M | 67.9K | — | — |
| Q4 2025 | $17.7M | 12.45M | — | — |
| Q3 2025 | $12.2M | 61.5K | — | — |
| Q3 2025 | $16.7M | 12.15M | — | — |
| Q2 2025 | $10M | 58.2K | — | — |
| Q2 2025 | $13.5M | 10.75M | — | — |
| Q1 2025 | $10.4M | 66.8K | — | — |
| Q1 2025 | $14.2M | 11.90M | — | — |
| Q4 2024 | $9.9M | 71.8K | — | — |
| Q4 2024 | $15.1M | 13.60M | — | — |
| Q3 2024 | $10.7M | 71.5K | — | — |
| Q3 2024 | $14.8M | 12.60M | — | — |
| Q2 2024 | $4.8M | 35.1K | — | — |
| Q2 2024 | $12.7M | 11.35M | — | — |
| Q1 2024 | $5.2M | 34.4K | — | — |
| Q1 2024 | $14.4M | 12.40M | — | — |
| Q4 2023 | $3.9M | 31.3K | — | — |
| Q4 2023 | $12.3M | 11.90M | — | — |
Other funds holding ASND
$290.4M
$175.4M
$122.6M